Influenza vaccine dosages

Vaccine

Volumn 26, Issue 19, 2008, Pages 2305-2306

  Palache, A M ^a   Beyer, W E P ^b   Osterhaus, A D M E ^b  

^a Solvay Biologicals BV   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; DOSE RESPONSE; HUMORAL IMMUNITY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LETTER; PRIORITY JOURNAL; VACCINATION; VIRUS STRAIN;

ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES;

EID: 42649108361     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.007     Document Type: Letter

References (2)

1. Couch R.B., Winokur P., Brady R., Belshe R., Chen W.H., Cate T.R., et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 25 (2007) 7656-7663
2. Palache A.M., Beyer W.E.P., Sprenger M.J.W., Masurel N., De Jonge S., Vardy A., et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 11 (1993) 3-7